Searchable abstracts of presentations at key conferences in endocrinology

ea0032p23 | Adrenal cortex | ECE2013

Immunohistochemical markers of adrenal cortical tumors

Altieri Barbara , Fadda Guido , Capozzi Anna , Pontecorvi Alfredo , Casa Silvia Della

Introduction: Adrenocortical tumors (ACTs) are usually divided in adenoma (ACA) or carcinoma (ACC) according to histopathologic methods. Some lesions are occasionally difficult to classify according to these criteria. We studied the use of some immunohistochemical markers to recognise the difference between malignant and benign tumors.Materials and methods: We studied 12 patients affected by ACC and 10 by ACA. Clinical evaluation and hormone analysis wer...

ea0029p879 | Endocrine tumours and neoplasia | ICEECE2012

A rare case of hirsutism: mucinous cystoadenoma of the ovary with stromal luteinization and hilar cell hyperplasia

Senes P. , Paragliola R. , Ricciato M. , Rossi E. , Fadda G. , Pontecorvi A. , Corsello S.

Introduction: Mucinous ovarian cystoadenoma with stromal luteinization and hilar cell hyperplasia is a rare cause of hirsutism and virilization and only few cases are described in literature. We present a rare case of mucinous cystadenoma with hypertestosteronemia.A 38-years old woman came to our observation for severe hirsutism and oligomenorrhea. Hormonal work-up showed severe hypertestosteronemia (total testosterone: 4.39 ng/ml) with high levels of DH...

ea0029p1558 | Steroid metabolism + action | ICEECE2012

Anabolic hormones in acute exacerbation of chronic obstructive pulmonary disease: relation of hypogonadism with indexes of severity and phlogosis

Berardino A. Di Marco , Mancini A. , Inchingolo R. , Raimondo S. , Segni C. Di , Pontecorvi A. , Valente S. , Corbo G.

Nowadays Chronic Obstructive Pulmonary Disease (COPD) is not considered a lung specific disease: nutritional alteration, weight loss due to increased energetic expenditure, loss of muscle mass are systemic effects, correlated with the risk of hospitalization due to exacerbation (AECOPD). AECOPD, characterised by augmented indexes like C reactive protein, interleukin-6, procalcitonin and serum amyloid A (SAA), negatively influenced natural history of the illness and were found ...

ea0026p85 | Endocrine tumours and neoplasia | ECE2011

Comments on a series of patients affected by MEN1

Veltri F , Fusco A , Lugli F , D'Uonnolo A , Lorusso M , Cimino V , Pontecorvi A , De Marinis L

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by variable combination of more than 20 types of endocrine and non-endocrine tumors: typically parathyroid glands, pancreatic islet cells and anterior pituitary gland are involved. We studied 20 patients (10M and 10F), affered to our Pituitary Unit in a period of 10 years. All patients had clinical diagnostic criteria suspected for MEN1 (presence of two endocrine tumors at least) and und...

ea0026p86 | Endocrine tumours and neoplasia | ECE2011

Role of peptide receptor radionuclide therapy (PRRT) in well and moderately differentiated neuroendocrine tumours

Bianchi A , Milardi D , Iacovazzo D , Tartaglione L , Grande G , Piacentini S , Pontecorvi A , De Marinis L

PRRT is a treatment choice for inoperable or metastasized neuroendocrine tumours and this therapy seems more effective in the biochemical and volume control of disease than SSA. We investigated the role of medical therapy with SSA and PRRT in patients with well and moderately differentiated neuroendocrine tumours. We evaluated 55 patients with well or moderately differentiated neuroendocrine tumours; 31 patients with either metastatic, unresectable or functioning tumours were ...

ea0026p312 | Obesity | ECE2011

Effects of natural dietary antioxidants on insulin and IGF1 in obese patients with insulin resistance

Mancini A , Magini M , Festa R , Raimondo S , Silvestrini A , Pontecorvi A , Meucci E , Martorana GE

Oxidative stress (OS) could play an important role in metabolic syndrome (MS)-related manifestations contributing to insulin resistance (IR). The reciprocal influences between OS and IR are not clear. We investigated the effects of dietary antioxidants on IR, studying 24 obese (7 males and 17 females, 27–66 years), with IR evaluated by HOMA index, during treatment with metformin, comparing 2 dietary treatments: hypocaloric diet (group A, n=16) or a diet enriched wi...

ea0014p606 | (1) | ECE2007

Validation of different insulin sensitivity indices in GH deficiency children using roc curve analysis

Baldelli R , Bellone S , Corneli G , Giampietro A , Cimino V , Pontecorvi A , De Marinis L , Bona G

Insulin sensitivity in GHD patients tends to decrease with age and variations in body composition. Several indices of insulin sensitivity have been considered and among these HOMA, ISI and QUICKI are based on mathematical calculations taking into account glucose and/or insulin levels either in basal conditions or after OGTT. Aim of present study was to validate the different indices in a population of pre-pubertal GHD children (n=66) by ROC curve analysis. All patients ...

ea0075m03 | Metabolic Bone | EYES2021

Management of a rare life-threatening parathyroid carcinoma

Zelano Lorenzo , Maggio Ettore , Veleno Miriam , Mura Chiara , Morgante Cesare , Antonio Rota Carlo , Pontecorvi Alfredo

Background: Parathyroid carcinoma (PC) is rare, usually presenting with hyperparathyroidism and severe hypercalcemia. A standardized diagnostic, prognostic and therapeutic approach has not been provided yet and TNM staging algorithm is not universally accepted. Surgery is the first-choice treatment and is the only effective therapy to control hypercalcaemia. Chemo- or radio-therapy, local treatments or novel drugs should be reserved to selected cases.Cas...

ea0075t11 | Thyroid | EYES2021

Safety profile of Lenvatinib treatment in a mildly symptomatic Covid19 patient

Menotti Sara , Mura Chiara , Corsello Andrea , Ramunno Vittoria , Raia Salvatore , Maria Rosa , Pontecorvi Alfredo

Background: Lenvatinib is an oral chemotherapy for metastatic radioiodine-refractory differentiated thyroid cancer (RRDTC) which significantly improves progression free survival (PFS). It has been proved that higher rates of dose interruption or reduction of Lenvatinib have a negative impact on PFS. Patients with active cancer, such as RRDTC, have an increased risk of contracting Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and developing complications, especial...

ea0049oc12.5 | Pituitary Clinical | ECE2017

Effects of pegvisomant and somatostatin receptor ligands on risk of vertebral fractures in patients with Acromegaly

Chiloiro Sabrina , Mazziotti Gherardo , Giampietro Antonella , Formenti Anna Maria , Bianchi Antonio , Mormando Marilda , Pontecorvi Alfredo , Giustina Andrea , De Marinis Laura

Acromegalic osteopathy is an emerging complication of chronic GH excess characterized by increase in bone turnover, deterioration in bone microarchitecture and high risk of vertebral fractures (VFs). Medical therapies may exert direct effects on peripheral targets leading to improvement of clinical outcomes regardless of biochemical control of acromegaly. In this longitudinal study, we compared the effects pegvisomant (PegV) and somatostatin receptor ligands (SRLs) on VF risk ...